Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dutasteride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 50 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO105948, NCT00363311
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 104274, NCT00375765
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 40 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: AVO108943, NCT00470834
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 35 to 90
Sponsor: Other
Protocol IDs: 047838, NCT00805701
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 45 to 80
Sponsor: Other
Protocol IDs: CURC/CUOG-AVIAS-0601, NCT00553878
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Phase: Phase III
Type: Prevention
Status: Completed
Age: 50 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARI40006, NCT00056407
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE14804, GSK106046 (formerly 103988), NCT00244309
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-374, NCT00953576
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 01253 - Committee 1, FHCRC-05026, 05-8538-V 01, 28741-A, 01253, NCT00298155
Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: Adult
Sponsor: Other
Protocol IDs: CDR0000514492, RPCI-I-34904, NCT00403000
ARTS - AVODART After Radical Therapy For Prostate Cancer Study
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 85
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARI109924, NCT00558363
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EH07-109, NCT00668642
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 09-008, NCT00853697
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: DUT112661, Health Canada-112661, NCT00866554
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-448, NCT01393730
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MDV3100-07, NCT01547299
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000596822, UCSF-05551, H7056-26910-03, 05551, GSK-UCSF-05551, NCT00706966
Start Over